NDC product
Succinylcholine Chloride
NDC 73043-021 · Devatis, Inc.
Key facts
| Product NDC | 73043-021 |
|---|---|
| Proprietary name | Succinylcholine Chloride |
| Nonproprietary name | Succinylcholine Chloride |
| Substances | SUCCINYLCHOLINE CHLORIDE |
| Dosage form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR, INTRAVENOUS |
| Labeler | Devatis, Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA214491 |
| Pharmacologic classes | Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE] |
| Marketing start | Sep 15, 2024 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: